학술논문

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Document Type
Article
Source
In Blood Advances 28 November 2023 7(22):6990-7005
Subject
Lymphoid Neoplasia
Clinical Trials and Observations
Immunobiology and Immunotherapy
Health Services and Outcomes
Language
ISSN
2473-9529